期刊
JOURNAL OF CLINICAL ONCOLOGY
卷 25, 期 26, 页码 4033-4042出版社
AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2007.11.3985
关键词
-
类别
资金
- NCI NIH HHS [R01 CA115767-03, R21 CA099237, R21 CA099237-02, P01 CA080124-08, R01 CA115767, P01 CA80124, P01 CA080124] Funding Source: Medline
Although still in very early stages of clinical development, the combination of antiangiogenics with contemporary chemoradiotherapy regimens has emerged as a feasible and promising approach to many cancers. We review the rationale and the current understanding of antiangiogenics and their therapeutic potential in combination with chemoradiotherapy. Finally, we offer a perspective on future research directions aimed at making this complex therapeutic approach successful in the clinic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据